Bioequivalence of tamsulosin 0.4 mg film-coated sustained-release tablet formulations in healthy subjects under fasting conditions
Int. Journal of Clinical Pharmacology and Therapeutics · 2025
DOI: 10.5414/cp204708 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, 2025. Verfasst von Raymond R Tjandrawinata und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Tamsulosin, Fasting, Adrenergic alpha-1 Receptor Antagonists.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Tjandrawinata, R. R., Yunaidi, D. A., Kurniawan, Y. I., Nindyatami, C., Saputro, I. D., Aziswan, S. A., Ginanjar, V. A., & Susanto, L. W. (2025). Bioequivalence of tamsulosin 0.4 mg film-coated sustained-release tablet formulations in healthy subjects under fasting conditions. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204708
Vancouver
Tjandrawinata RR, Yunaidi DA, Kurniawan YI, Nindyatami C, Saputro ID, Aziswan SA, et al. Bioequivalence of tamsulosin 0.4 mg film-coated sustained-release tablet formulations in healthy subjects under fasting conditions. Int. Journal of Clinical Pharmacology and Therapeutics. 2025. doi:10.5414/cp204708
BibTeX
@article{Tjandrawinata2025,
author = {Tjandrawinata, Raymond R and Yunaidi, Danang Agung and Kurniawan, Yantirta Indra and Nindyatami, Clarasintha and Saputro, Ismail Dwi and Aziswan, Syifa Anugriani and Ginanjar, Vicky Achmad and Susanto, Liana W},
title = {Bioequivalence of tamsulosin 0.4 mg film-coated sustained-release tablet formulations in healthy subjects under fasting conditions},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2025},
doi = {10.5414/cp204708}
}
EUVIMED